Prognosis and treatment is the same as for the most common type of ovarian cancer, which is epithelial ovarian cancer. The median survival of<unk> s is usually shorter by 2–6 months time when compared with serous ovarian cancer. Studies show median survival varies between 11.3 and 17.8 months. One study reported 19–40 month median survival (95% CI) with a five-year survival of 26.5%. Elevated albumin levels have been associated with a more favorable prognosis.
Primary peritoneal carcinoma
Peritoneal mesothelioma
Peritoneal carcinomatosis
Intravenous leiomyomatosis
Metastatic breast cancer
Pseudomyxoma peritonei
Metastatic carcinoma
Comedocarcinoma